Ubs Group Ag Neogenomics Inc Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Neogenomics Inc stock. As of the latest transaction made, Ubs Group Ag holds 375,805 shares of NEO stock, worth $3.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
375,805
Previous 498,321
24.59%
Holding current value
$3.45 Million
Previous $4.73 Million
41.91%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$130 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$68.1 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$62.8 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$46.9 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.15B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...